CN105456216B - 盐酸普拉克索缓释片剂组合物及其制备方法 - Google Patents
盐酸普拉克索缓释片剂组合物及其制备方法 Download PDFInfo
- Publication number
- CN105456216B CN105456216B CN201410404231.9A CN201410404231A CN105456216B CN 105456216 B CN105456216 B CN 105456216B CN 201410404231 A CN201410404231 A CN 201410404231A CN 105456216 B CN105456216 B CN 105456216B
- Authority
- CN
- China
- Prior art keywords
- utech
- content
- release
- pramipexole
- total
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
成分 | 含量(mg)/片 |
盐酸普拉克索 | 0.75 |
尤特奇 RSPO | 87.50 |
尤特奇S100 | 7.00 |
羟丙基甲基纤维素 | 70.00 |
预胶化淀粉 | 181.34 |
气相二氧化硅 | 1.50 |
硬脂酸镁 | 1.75 |
合计 | 350mg |
成分 | 含量(mg)/片 |
盐酸普拉克索 | 0.75 |
尤特奇 RLPO | 87.50 |
尤特奇S100 | 10.50 |
羟丙基甲基纤维素 | 77.00 |
预胶化淀粉 | 171.01 |
气相二氧化硅 | 1.50 |
硬脂酸镁 | 1.75 |
合计 | 350mg |
成分 | 含量(mg)/片 |
盐酸普拉克索 | 0.75 |
尤特奇 RD100 | 98.00 |
尤特奇S100 | 14.35 |
羟丙基甲基纤维素 | 87.5 |
预胶化淀粉 | 146.16 |
气相二氧化硅 | 1.50 |
硬脂酸镁 | 1.75 |
合计 | 350mg |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410404231.9A CN105456216B (zh) | 2014-08-18 | 2014-08-18 | 盐酸普拉克索缓释片剂组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410404231.9A CN105456216B (zh) | 2014-08-18 | 2014-08-18 | 盐酸普拉克索缓释片剂组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105456216A CN105456216A (zh) | 2016-04-06 |
CN105456216B true CN105456216B (zh) | 2019-11-05 |
Family
ID=55594684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410404231.9A Active CN105456216B (zh) | 2014-08-18 | 2014-08-18 | 盐酸普拉克索缓释片剂组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105456216B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110227067B (zh) * | 2019-06-10 | 2021-03-02 | 深圳翰宇药业股份有限公司 | 一种盐酸普拉克索缓释片及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101005831A (zh) * | 2004-08-13 | 2007-07-25 | 贝林格尔·英格海姆国际有限公司 | 包含普拉克索或其可药用盐的延长释放片剂 |
CN101022788A (zh) * | 2004-08-13 | 2007-08-22 | 贝林格尔·英格海姆国际有限公司 | 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途 |
CN102357087A (zh) * | 2011-10-26 | 2012-02-22 | 山东齐都药业有限公司 | 一种富马酸美托洛尔缓释片及其制备方法 |
CN102406626A (zh) * | 2011-12-02 | 2012-04-11 | 深圳海王药业有限公司 | 盐酸普拉克索缓释片剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007090881A2 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Modified release formulation |
KR101307334B1 (ko) * | 2010-07-02 | 2013-09-12 | 주식회사 바이오파마티스 | 프라미펙솔 또는 이의 약학적으로 허용되는 염을 포함하는 안정성이 개선된 서방형 약학 조성물 |
-
2014
- 2014-08-18 CN CN201410404231.9A patent/CN105456216B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101005831A (zh) * | 2004-08-13 | 2007-07-25 | 贝林格尔·英格海姆国际有限公司 | 包含普拉克索或其可药用盐的延长释放片剂 |
CN101022788A (zh) * | 2004-08-13 | 2007-08-22 | 贝林格尔·英格海姆国际有限公司 | 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途 |
CN102357087A (zh) * | 2011-10-26 | 2012-02-22 | 山东齐都药业有限公司 | 一种富马酸美托洛尔缓释片及其制备方法 |
CN102406626A (zh) * | 2011-12-02 | 2012-04-11 | 深圳海王药业有限公司 | 盐酸普拉克索缓释片剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105456216A (zh) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5775464B2 (ja) | 非晶質cddo−meを含有する遅延放出性経口投薬組成物 | |
TW200942273A (en) | Drug delivery systems comprising weakly basic drugs and organic acids | |
JP6449451B2 (ja) | メトホルミン徐放性製剤及びその製造方法 | |
TWI419716B (zh) | 奈韋拉平(nevirapine)之延長釋放調配劑 | |
JP2010508353A (ja) | エルブシタビン薬学的組成物 | |
WO2011079609A1 (zh) | 一种固体制剂的制备方法及所得固体制剂 | |
CN109875972B (zh) | 一种奥美沙坦酯氨氯地平药物组合物 | |
KR20190139942A (ko) | 개선된 지속 방출형의 고도로 적재되는 약물 조성물 | |
WO2020175897A1 (ko) | 미라베그론 또는 그의 약제학적으로 허용되는 염을 함유한 방출조절 제제 | |
EP2403487A2 (en) | Oral controlled release dosage forms for water soluble drugs | |
CN102406626A (zh) | 盐酸普拉克索缓释片剂及其制备方法 | |
KR20140041641A (ko) | 이토프라이드 염산염을 함유하는 제어 방출성 경구 제제의 조성물 및 그의 제조방법 | |
CN105456216B (zh) | 盐酸普拉克索缓释片剂组合物及其制备方法 | |
EP3437645B1 (en) | Film-coated tablet having high chemical stability of active ingredient | |
CN105878256A (zh) | 含有盐酸二甲双胍和格列美脲的控释制剂及其制备方法 | |
KR101761983B1 (ko) | 구강내 속붕해 필름 조성물 및 그 제조방법 | |
EP3796908B1 (en) | Controlled release propiverine formulations | |
CN103989643B (zh) | 含有雷美替胺和共聚维酮的片剂 | |
CN103550182B (zh) | 一种肠溶缓释组合物 | |
EP4262799A1 (en) | Homogenous compositions of propiverine hci formulations | |
CN111939135A (zh) | 一种盐酸二甲双胍药物的缓释片及其制备方法 | |
JP2008201706A (ja) | 小型徐放性錠剤 | |
KR20200061225A (ko) | 바레니클린 서방성 제제의 건식 제조 방법 | |
CN106474084B (zh) | 一种盐酸普拉克索缓释制剂及其制备方法 | |
TWI744858B (zh) | 治療精神疾病之控釋藥物組合物和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: 224200 Jiangsu Province, Yancheng City Dongtai City Ho duo Road No. 18 Applicant after: Jiangsu Shenlong pharmaceutical Limited by Share Ltd Applicant after: Chinese Medicinal Univ. Applicant after: Jiangsu Chengchuang Drug R & D Co.,Ltd. Address before: 224200 Jiangsu Province, Yancheng City Dongtai City Ho duo Road No. 18 Applicant before: Jiangsu Shenlong Pharmaceutical Co., Ltd. Applicant before: Chinese Medicinal Univ. Applicant before: Jiangsu Chengchuang Drug R & D Co.,Ltd. |
|
COR | Change of bibliographic data | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 224299 No. 15 Weiba Road, Dongtai City, Yancheng City, Jiangsu Province Co-patentee after: CHINA PHARMACEUTICAL University Patentee after: JIANGSU SHENLONG PHARMACEUTICAL Co.,Ltd. Co-patentee after: JIANGSU CHENGCHUANG NEW DRUG R&D Co.,Ltd. Address before: 224200, No. 18 North Road, Dongtai, Jiangsu, Yancheng City Co-patentee before: CHINA PHARMACEUTICAL University Patentee before: JIANGSU SHENLONG PHARMACEUTICAL Co.,Ltd. Co-patentee before: JIANGSU CHENGCHUANG NEW DRUG R&D Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 224299 No. 15 Weiba Road, Dongtai City, Yancheng City, Jiangsu Province Patentee after: JIANGSU SHENLONG PHARMACEUTICAL Co.,Ltd. Patentee after: CHINA PHARMACEUTICAL University Patentee after: JIANGSU CHENGCHUANG NEW DRUG R&D Co.,Ltd. Address before: 224299 No. 15 Weiba Road, Dongtai City, Yancheng City, Jiangsu Province Patentee before: JIANGSU SHENLONG PHARMACEUTICAL Co.,Ltd. Patentee before: CHINA PHARMACEUTICAL University Patentee before: JIANGSU CHENGCHUANG NEW DRUG R&D Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |